Nanoparticle‐Embedded GelMA/NIPAm Hydrogels: A Temperature‐Responsive Hybrid System for Controlled Drug Release
Macromolecular Bioscience · 2026-01 · 26 (1)
DOI: 10.1002/mabi.202400635 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Bioscience, online erschienen am 29.06.2025. Verfasst von Maria Daaboul und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Faculty of Chemical and Metallurgical Engineering, Yildiz Technical University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Hydrogels, Nanoparticles, Gelatin, Acrylamides. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Scientific and Technological Research Council of Turkey (TÜBİTAK).
Abstract (Originalsprache)
Temperature‐responsive hydrogels incorporating drug‐loaded polymeric nanoparticles represent a significant advancement in controlled release systems, enabling responsive and environmentally triggered drug delivery. In this study, a novel temperature‐responsive drug delivery system was developed based on a gelatin methacryloyl/N‐isopropylacrylamide (GelMA/NIPAm) hydrogel incorporating phenytoin (PHT)‐loaded poly(D,L‐lactide‐co‐glycolide) (PLGA) nanoparticles. For this, empty nanoparticles, PHT‐loaded nanoparticles, bare hydrogels (BH), empty nanoparticle‐loaded hydrogels (eNP‐H), and PHT‐encapsulated nanoparticle‐embedded hydrogels (PHT‐H) were prepared and characterized using FTIR, SEM, DSC, XRD, DLS, swelling, drug release, and biocompatibility tests. The drug‐loaded nanoparticles exhibited hydrodynamic diameter of 223.7 ± 8.4 nm with a PDI of 0.298 and a zeta potential of –20.4 mV. The BH, eNP‐H, and PHT‐H hydrogels displayed similar temperature‐dependent swelling, with approximate weight swelling ratios of 9.0 at 25°C, 7.5 at 37°C, and 6.0 at 40°C. Swelling kinetics showed that all hydrogels reached equilibrium within 20 min. Moreover, the hydrogels demonstrated consistent cyclic swelling and shrinking at 37°C and 40°C. Drug release studies revealed that PHT‐H hydrogels released ∼20% of phenytoin at 37°C and ∼34% at 40°C over 7 days, confirming sustained, temperature‐responsive drug release. Cell viability assays indicated no cytotoxicity and potential promotion of cell proliferation. Thus, these hydrogels offer a promising platform for efficient, temperature‐sensitive, and controlled drug delivery applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, Faculty of Chemical and Metallurgical Engineering, Yildiz Technical University, Istanbul, Turkey.
- Institute of Health Sciences, Marmara University, Istanbul, Turkey.
- Center for Nanotechnology & Biomaterials Application and Research (NBUAM), Marmara University, Istanbul, Turkey.
- Department of Metallurgical and Materials Engineering, Faculty of Technology, Marmara University, Istanbul, Turkey.
- Department of Biophysics, School of Medicine, Marmara University, Istanbul, Turkey.
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Marmara University, Istanbul, Turkey.
ORCID-Profile: Mehmet Murat Ozmen
Förderung
- Scientific and Technological Research Council of Turkey (TÜBİTAK)
Zitieren
APA
Daaboul, M., Akkaya, A., Kanli, Z., Gunduz, O., Aydın, B., Alarcin, E., Ozmen, M. M., & Topuzogullari, M. (2026). Nanoparticle‐Embedded GelMA/NIPAm Hydrogels: A Temperature‐Responsive Hybrid System for Controlled Drug Release. Macromolecular Bioscience, 26(1). https://doi.org/10.1002/mabi.202400635
Vancouver
Daaboul M, Akkaya A, Kanli Z, Gunduz O, Aydın B, Alarcin E, et al. Nanoparticle‐Embedded GelMA/NIPAm Hydrogels: A Temperature‐Responsive Hybrid System for Controlled Drug Release. Macromolecular Bioscience. 2026;26(1). doi:10.1002/mabi.202400635
BibTeX
@article{Daaboul2026,
author = {Daaboul, Maria and Akkaya, Ayse and Kanli, Zehra and Gunduz, Oguzhan and Aydın, Banu and Alarcin, Emine and Ozmen, Mehmet Murat and Topuzogullari, Murat},
title = {Nanoparticle‐Embedded GelMA/NIPAm Hydrogels: A Temperature‐Responsive Hybrid System for Controlled Drug Release},
journal = {Macromolecular Bioscience},
year = {2026},
volume = {26},
number = {1},
doi = {10.1002/mabi.202400635}
}
EUVIMED